SG Talk
SG Talk
>
SG Talk
>
Market Talk
> Covaxin approval:WHO likely to reconvene on Nov3 for final risk-benefit assessment
Full Version:
Covaxin approval:WHO likely to reconvene on Nov3 for final risk-benefit assessment
You're currently viewing a stripped down version of our content.
View the full version
with proper formatting.
theold
02-11-2021, 01:19 PM
https://www.indiatoday.in/coronavirus-ou...2021-10-27
SG Talk
>
SG Talk
>
Market Talk
> Covaxin approval:WHO likely to reconvene on Nov3 for final risk-benefit assessment